CureMatch Decision Support Software

CureMatch has launched their decision support software platform to select combinations of cancer therapies based on tumor molecular profiling. The software considers data from clinical trials, publications, and drug interaction databases, along with the patient's genetic profile, to comb through more than 4.5 million possible combination therapy options.